Statement re Grant of Options and Warrants

33 minutes ago
GlobeNewswire

DXS INTERNATIONAL PLC (AQSE: DXSP) Granting of Share Options and Warrants The Board of DXS International plc (the “Company” or…

eeden Closes €18M Series A Financing to Scale its Breakthrough Textile Recycling Technology

33 minutes ago

eeden - Series A - l. Steffen Gerlach, CEO & Co-Founder - r. Dr. Tobias Börnhost, CTO & Co-Founder l.…

Bank of Åland Plc: Interim Report for the period January – March 2025

33 minutes ago

  Bank of Åland PlcInterim ReportApril 29, 2025 9.00 EET Interim Report for the period January - March 2025 A strong…

DOVRE GROUP TRADING STATEMENT JANUARY 1 – MARCH 31, 2025

48 minutes ago

Dovre Group Plc        Stock exchange release        April 29, 2025, at 8:45 a.m. DOVRE GROUP TRADING STATEMENT JANUARY 1 – MARCH 31, 2025…

Headwall Group and Laitram Machinery Announce Deployment of Hyperspectral Technology in Food Processing

1 hour ago

Pivotal step in deploying hyperspectral technology across food processing industries at an industrial scale Laitram Machinery Logo Laitram Machinery Logo…

eQ Plc’s interim report Q1 2025 – eQ’s operating profit EUR 5.8 million

2 hours ago

eQ Plc interim report29 April 2025 at 8:00 AM   January to March 2025 in brief During the period under review,…

Lassila & Tikanoja plc: Interim Report 1 January–31 March 2025

2 hours ago

Lassila & Tikanoja plc Stock exchange release 29 April 2025 at 8:00 a.m Lassila & Tikanoja plc: Interim Report 1…

Clariant delivers further improved profitability in challenging environment – outlook confirmed

2 hours ago

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR FIRST QUARTER | 2025 Q1 2025 sales increased by 1 % in local currencies1…

Aspocomp’s Interim Report January 1-March 31, 2025: Order book, and net sales increased significantly, and the operating result turned clearly profitable

2 hours ago

Aspocomp Group Plc, Interim Report, April 29, 2025, at 8:00 a.m. (Finnish time)JANUARY-MARCH 2025 HIGHLIGHTS Net sales EUR 10.3 (6.2)…

Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update

2 hours ago

Vivoryon Therapeutics N.V. Reports Full Year 2024 Financial Results and Provides Business Update Successful strategic shift towards a focus on…

This website uses cookies.